A Case of Toxic Megacolon Caused by Clostridium difficile Infection and Treated with Fecal Microbiota Transplantation
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Toxic megacolon is a rare clinical complication of fulminant Clostridium difficile infection. The mortality rate of fulminant C. difficile infection is reported to be as high as 50%. Fecal microbiota transplantation is a highly effective treatment in patients with recurrent or refractory C. difficile infection. However, there are few published articles on the use of such transplantation for fulminant C. difficile infection. Here, we report on a patient with toxic megacolon complicated by C. difficile infection who was treated successfully with fecal microbiota transplantation.
Abstract
Toxic megacolon is a rare clinical complication of fulminant Clostridium difficile infection. The mortality rate of fulminant C. difficile infection is reported to be as high as 50%. Fecal microbiota transplantation is a highly effective treatment in patients with recurrent or refractory C. difficile infection. However, there are few published articles on the use of such transplantation for fulminant C. difficile infection. Here, we report on a patient with toxic megacolon complicated by C. difficile infection who was treated successfully with fecal microbiota transplantation.
참고문헌 (12)
- Freeman J, "The changing epidemiology of Clostridium difficile infections", Clin Microbiol Rev, 23, pp.529~549 (2010)
- O’Connor JR, "Clostridium difficile infection caused by the epidemic BI", NAP1, Gastroenterology, pp.2009, 136[DOI]
- Lamontagne F, "Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain", Ann Surg, 245, pp.267~272 (2007)
- Sailhamer EA, "Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality", Arch Surg, 144, pp.433~439 (2009)
- Dallal RM, "Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications", Ann Surg, 235, pp.363~372 (2002)
- Jaber MR, "Clinical review of the management of fulminant clostridium difficile infection", Am J Gastroenterol, 103, pp.3195~3203 (2008)
- Cohen SH, "Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)", Infect Control Hosp Epidemiol, 31, pp.431~455 (2010)
- McPherson S, "Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea", Dis Colon Rectum, 49, pp.640~645 (2006)
- Abougergi MS, "Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review", Dig Dis Sci, 56, pp.19~26 (2011)
- Hamilton MJ, "Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection", Am J Gastroenterol, 107, pp.761~767 (2012)
- Brandt LJ, "Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection", Am J Gastroenterol, 107, pp.1079~1087 (2012)
- Warny M, "Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe", Lancet, 366, pp.1079~1084 (2005)